212 related articles for article (PubMed ID: 26101717)
1. MYBL2 is an independent prognostic marker that has tumor-promoting functions in colorectal cancer.
Ren F; Wang L; Shen X; Xiao X; Liu Z; Wei P; Wang Y; Qi P; Shen C; Sheng W; Du X
Am J Cancer Res; 2015; 5(4):1542-52. PubMed ID: 26101717
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of gene DEP domain containing 1 and its clinical prognostic significance in colorectal cancer.
Shen X; Han J
J Clin Lab Anal; 2020 Dec; 34(12):e23634. PubMed ID: 33140894
[TBL] [Abstract][Full Text] [Related]
3. Role of MUC20 overexpression as a predictor of recurrence and poor outcome in colorectal cancer.
Xiao X; Wang L; Wei P; Chi Y; Li D; Wang Q; Ni S; Tan C; Sheng W; Sun M; Zhou X; Du X
J Transl Med; 2013 Jun; 11():151. PubMed ID: 23787019
[TBL] [Abstract][Full Text] [Related]
4. The prognostic significance of bromodomain PHD-finger transcription factor in colorectal carcinoma and association with vimentin and E-cadherin.
Xiao S; Liu L; Lu X; Long J; Zhou X; Fang M
J Cancer Res Clin Oncol; 2015 Aug; 141(8):1465-74. PubMed ID: 25716692
[TBL] [Abstract][Full Text] [Related]
5. Bromodomain-containing protein 9 activates proliferation and epithelial-mesenchymal transition of colorectal cancer via the estrogen pathway
Chen P; Du R; Chang Z; Gao W; Zhao W; Dong G
J Gastrointest Oncol; 2023 Apr; 14(2):980-996. PubMed ID: 37201092
[TBL] [Abstract][Full Text] [Related]
6. Alpha B-crystallin promotes the invasion and metastasis of colorectal cancer via epithelial-mesenchymal transition.
Shi C; Yang X; Bu X; Hou N; Chen P
Biochem Biophys Res Commun; 2017 Aug; 489(4):369-374. PubMed ID: 28506831
[TBL] [Abstract][Full Text] [Related]
7. [High expression of MYBL2 promotes progression and predicts a poor survival outcome of prostate cancer].
Yang M; Zhu X; Shen Y; He Q; Qin Y; Shao Y; Yuan L; Ye H
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Aug; 42(8):1109-1118. PubMed ID: 36073208
[TBL] [Abstract][Full Text] [Related]
8. Abnormal expression of GADD45B in human colorectal carcinoma.
Wang L; Xiao X; Li D; Chi Y; Wei P; Wang Y; Ni S; Tan C; Zhou X; Du X
J Transl Med; 2012 Oct; 10():215. PubMed ID: 23110778
[TBL] [Abstract][Full Text] [Related]
9. Decreased expression of semaphorin 3D is associated with genesis and development in colorectal cancer.
Wang Z; Ding M; Qian N; Song B; Yu J; Tang J; Wang J
World J Surg Oncol; 2017 Mar; 15(1):67. PubMed ID: 28320475
[TBL] [Abstract][Full Text] [Related]
10. The high expression of long non-coding RNA PANDAR indicates a poor prognosis for colorectal cancer and promotes metastasis by EMT pathway.
Lu M; Liu Z; Li B; Wang G; Li D; Zhu Y
J Cancer Res Clin Oncol; 2017 Jan; 143(1):71-81. PubMed ID: 27629879
[TBL] [Abstract][Full Text] [Related]
11. N-cadherin, a novel prognostic biomarker, drives malignant progression of colorectal cancer.
Yan X; Yan L; Liu S; Shan Z; Tian Y; Jin Z
Mol Med Rep; 2015 Aug; 12(2):2999-3006. PubMed ID: 25936636
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of RPN2 induces apoptosis and inhibits migration and invasion in colon carcinoma.
Bi C; Jiang B
Oncol Rep; 2018 Jul; 40(1):283-293. PubMed ID: 29749494
[TBL] [Abstract][Full Text] [Related]
13. SPP1, analyzed by bioinformatics methods, promotes the metastasis in colorectal cancer by activating EMT pathway.
Xu C; Sun L; Jiang C; Zhou H; Gu L; Liu Y; Xu Q
Biomed Pharmacother; 2017 Jul; 91():1167-1177. PubMed ID: 28531945
[TBL] [Abstract][Full Text] [Related]
14. Prognostic implications and oncogenic roles of MYBL2 protein expression in esophageal squamous-cell carcinoma.
Qin H; Li Y; Zhang H; Wang F; He H; Bai X; Li S
Onco Targets Ther; 2019; 12():1917-1927. PubMed ID: 30881043
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of long non-coding RNA-CTD903 inhibits colorectal cancer invasion and migration by repressing Wnt/β-catenin signaling and predicts favorable prognosis.
Yuan Z; Yu X; Ni B; Chen D; Yang Z; Huang J; Wang J; Chen D; Wang L
Int J Oncol; 2016 Jun; 48(6):2675-85. PubMed ID: 27035092
[TBL] [Abstract][Full Text] [Related]
16. Aberrant expression of stress-induced phosphoprotein 1 in colorectal cancer and its clinicopathologic significance.
Zhang Z; Ren H; Yang L; Zhang X; Liang W; Wu H; Huang L; Kang J; Xu J; Zhai E; Cai S; He Y
Hum Pathol; 2018 Sep; 79():135-143. PubMed ID: 29879402
[TBL] [Abstract][Full Text] [Related]
17. High expression of fibronectin is associated with poor prognosis, cell proliferation and malignancy via the NF-κB/p53-apoptosis signaling pathway in colorectal cancer.
Yi W; Xiao E; Ding R; Luo P; Yang Y
Oncol Rep; 2016 Dec; 36(6):3145-3153. PubMed ID: 27748871
[TBL] [Abstract][Full Text] [Related]
18. miR-422a is an independent prognostic factor and functions as a potential tumor suppressor in colorectal cancer.
Zheng GX; Qu AL; Yang YM; Zhang X; Zhang SC; Wang CX
World J Gastroenterol; 2016 Jun; 22(24):5589-97. PubMed ID: 27350737
[TBL] [Abstract][Full Text] [Related]
19. DCLK1 is up-regulated and associated with metastasis and prognosis in colorectal cancer.
Gao T; Wang M; Xu L; Wen T; Liu J; An G
J Cancer Res Clin Oncol; 2016 Oct; 142(10):2131-40. PubMed ID: 27520310
[TBL] [Abstract][Full Text] [Related]
20. MYBL2 is a Potential Prognostic Marker that Promotes Cell Proliferation in Gallbladder Cancer.
Liang HB; Cao Y; Ma Q; Shu YJ; Wang Z; Zhang F; Ye YY; Li HF; Xiang SS; Song XL; Xu Y; Zhang YC; Bao RF; Yuan RY; Zhang YJ; Hu YP; Jiang L; Li ML; Wang XA; Wu XS; Wu WG; Zhao S; Fand Y; Cui XP; Lu YS; Zhou J; Zheng L; Gong W; Liu YB
Cell Physiol Biochem; 2017; 41(5):2117-2131. PubMed ID: 28427077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]